ArticleCureus2025
Effect of the Modified Dietary Approach to Stop Hypertension (DASH) Diet on Glycemic Control and Insulin Resistance in Patients With Diabetes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between Five Established DASH Diet Indices and Risk of Type 2 Diabetes Mellitus: A Population-Based Prospective Cohort Study.Archives of Iranian medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundType 2 diabetes mellitus (T2DM) is a chronic metabolic disease largely fueled by insulin resistance and defective insulin secretion. Nutritional modification is a central aspect of glycemic control and the prevention of diabetes-related complications. The Dietary Approach to Stop Hypertension (DASH) diet, initially designed to treat hypertension, has demonstrated encouraging evidence in enhancing metabolic control in T2DM when appropriately adapted. The aim of this study was to assess the impact of a modified DASH diet on insulin resistance and glycemic control among adults with T2DM.
methodsThis quasi-experimental non-randomized trial was conducted at Lady Hardinge Medical College and Associated Hospitals, New Delhi, from May 2023 to November 2024. Sixty patients with T2DM (glycated hemoglobin or HbA1c < 7.5%) were assigned to two groups: Group A (n = 30) received counseling on a modified DASH diet, and Group B (n = 30) was provided with a standard diabetic diet. Baseline and 12-week assessments consisted of fasting blood glucose (FBG), serum insulin, HbA1c, lipid profile, BMI, and homeostatic model assessment of insulin resistance (HOMA-IR). Dietary compliance was reinforced with regular follow-up.
resultsAt baseline, the two groups were similar in age, BMI, and glycemic measures. Group A showed significantly greater decreases at 12 weeks in FBG (p = 0.001), HbA1c (within-group p < 0.001; between-group p = 0.057), and BMI (p < 0.001) compared to Group B. The reduction in HOMA-IR was also more significant in Group A, although intergroup changes at 12 weeks were significant at a borderline level but failed to meet the threshold for statistical significance. Generalized estimating equation analysis validated notable within-group changes in Group A in weight, BMI, and glycemic parameters.
conclusionThe modified DASH diet demonstrated improved glycemic control, insulin resistance, and weight results at 12 weeks compared to a normal diabetic diet. These data attest to its utility as an effective dietary approach in the overall management of T2DM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.